The new guidelines describe the features of chronic pulmonary aspergillosis (CPA) and provide comprehensive treatment recommendations.
Researchers designed a case-control study using de-identified commercial health claim information in the United States from January 1, 2007, to December 31, 2009.
Treatment was tested in critically ill patients with ICU-acquired sepsis, multiple Candida colonization, and multiple organ failure.
Flu may represent a novel host risk factor for this invasive fungal infection.
The updated guidelines focus on the diagnosis and treatment of the major forms of aspergillosis: allergic, chronic and invasive, the latter which kills 40% to 80% of those with widespread infection.
Drs Tapper and Crum-Cianflone discuss aspergillosis, an emerging complication of severe influenza infections.
Rapid identification of Candida auris is crucial in order to implement appropriate precautions and avoid transmission to other patients.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- The Misuse of Antibiotics in Acute Pancreatitis Appears Widespread
- ART Reduces Neurocognitive Impairment in Patients Living With HIV
- Tackling the Challenges Associated With Treating Hepatitis C Infection in Pediatric Patients
- Mental Health Problems in Adolescents With HIV: Overview & Expert Interview
- Severity of Acute Respiratory Infections in Children Affected by Viral Etiology
- Antibiotic Prophylaxis Before Dental Procedures May Be Unnecessary
- Penicillin Allergies: Commonly Reported but Rarely Accurate
- Irritable Bowel Syndrome Treatments
- Oral Ciprofloxacin Effective in Treatment for Bacteremia
- Need for Adequate Screening for Infants With HCV Infected Mothers During Pregnancy
- Viral Suppression in Children on ART Identified Via Quantitative HIV Antibody Levels
- Patient Develops Glandular Tularemia After Taking Care of Sick Cat
- Internet-Based Intervention Can Reduce Depression in People Living With HIV
- Prophylaxis With TMP-SMX Did Not Alter Risk for Non-UTI Infections
- Low Recurrence With Shortened IV Abx Course in GBS Bacteremia